Subscribe to Newsletter

William Aryitey

My fascination with science, gaming, and writing led to my studying biology at university, while simultaneously working as an online games journalist. After university, I travelled across Europe, working on a novel and developing a game, before finding my way to Texere. As Associate Editor, I’m evolving my loves of science and writing, while continuing to pursue my passion for gaming and creative writing in a personal capacity.

Content by William Aryitey:

Business & Regulation Standards & Regulation

The FDA Abroad

| William Aryitey

The US regulatory agency has enlisted other authorities in Europe to carry out inspections.

Manufacture Quality & Compliance

Learning from Failure

| William Aryitey

Over 90 percent of drugs fail to make it to market. What can the industry do to change that?

Manufacture Technology and Equipment

Mini Mimic

| William Aryitey

Could body-on-chip platforms eventually replace current pre-clinical animal models?

Business & Regulation Business Practice

Steady On, Pharma

| William Aryitey

Pharma’s 2022 growth forecast has been reduced for the first time in a decade.

Business & Regulation Biosimilars

Business-in-Brief

| William Aryitey

EMA relocation, a price-fixing scandal, and FDA warning letters… What's new for pharma in business?

Discovery & Development Drug Delivery

An All-in-One Vaccine

| William Aryitey

The solution to multiple drugs co-existing in a syringe may lie with microparticles

Business & Regulation Business Practice

Business-in-Brief

| William Aryitey

Record generic approvals, a joint opioid investigation... What’s new for pharma in business?

Manufacture Small Molecules

Skin in the Game

| William Aryitey

Could donated skin be a viable alternative to animal testing?

Business & Regulation Business Practice

IP Deal or No Deal?

| William Aryitey

The future status of pharma intellectual property in the UK depends on the outcome of Brexit.

Manufacture Standards & Regulation

What’s on the Box?

| William Aryitey

The US and and EU deadlines are approaching, but is the industry ready for serialization?

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register